S-531011

S-531011 · Shionogi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S-531011, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

See pricing